John F. Chin
Director/Board Member presso ANTENGENE CORPORATION LIMITED
Patrimonio netto: 233 244 $ in data 31/03/2024
Posizioni attive di John F. Chin
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ANTENGENE CORPORATION LIMITED | Director/Board Member | 18/08/2020 | - |
| Corporate Officer/Principal | 18/08/2020 | - | |
Aventis Pharmaceuticals, Inc.
 Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 01/10/1998 | - |
Antengene Corporation Co., Ltd.
 Antengene Corporation Co., Ltd. Pharmaceuticals: MajorHealth Technology Antengene Corporation Co., Ltd. operates as a holding company. It engages in clinical development of drug candidates. The company was founded on June 15, 2016 and is headquartered in Shanghai, China. | Director/Board Member | - | - |
| Corporate Officer/Principal | - | - |
Storia della carriera di John F. Chin
Precedenti posizioni note di John F. Chin
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CELGENE | Corporate Officer/Principal | 01/01/2005 | 01/01/2020 |
Formazione di John F. Chin
| Pepperdine University | Masters Business Admin |
| University of Arizona | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
| Cina | 3 |
Posizioni
| Corporate Officer/Principal | 4 |
| Director/Board Member | 2 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ANTENGENE CORPORATION LIMITED | Health Technology |
| Aziende private | 3 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Aventis Pharmaceuticals, Inc.
Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Health Technology |
Antengene Corporation Co., Ltd.
Antengene Corporation Co., Ltd. Pharmaceuticals: MajorHealth Technology Antengene Corporation Co., Ltd. operates as a holding company. It engages in clinical development of drug candidates. The company was founded on June 15, 2016 and is headquartered in Shanghai, China. | Health Technology |
- Borsa valori
- Insiders
- John F. Chin
- Esperienza
